Proteomics model picks breast cancer drugs from biopsies
A virtual-cell model trained on 38 million protein measurements matched real treatment outcomes in women with triple-negative breast cancer.
Trending Now
Robinhood Ventures Fund II brings retail capital to healthcare AI
The NYSE-listed BDC devotes about 6.7% of assets to early-stage healthcare AI, from cancer screening to clinic operations.
Consumer chatbots are building a medical system outside hospitals
Two Harvard-affiliated physicians warn consumer chatbots are quietly building a parallel medical…
Reasoning gaps hold back AI agents in scientific discovery
MIT Technology Review argues AI agents need reasoning, not just more data,…
Stanford Health AI Week Highlights AI’s Growing Role in Medical Education, Patient Empowerment, and Life Sciences
Stanford Medicine's weeklong Health AI event across eight symposia explored how AI is empowering patients, reshaping medical education, accelerating cancer…
AI Emerges as a Game-Changer in Humanitarian Healthcare Crisis Response
AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…
HKUST Pioneers Micro-Robotics and AI Tools to Reshape Global Healthcare
From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…
High-Quality Data Is Key to Unlocking AI’s Full Potential in Clinical Trials
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…
Volta Medical’s AI-Guided AF-Xplorer Earns Landmark U.S. Label Expansion Following Breakthrough TAILORED-AF Trial Results
Volta Medical’s AF-Xplorer becomes the first AI system with level one clinical evidence to improve…
Breath analysis AI scores $19M as COPD diagnosis crisis deepens
The NHS COPD backlog of 600K patients drives TidalSense's $19M raise for its 75-second AI…
Bridging the Gap Between AI Adoption and HIPAA Compliance
Modern AI tools can reidentify patients by cross matching data fragments, requiring healthcare staff to…
Balancing AI Innovation with Governance in Healthcare
As AI transforms drug discovery, care delivery, and claims processing, healthcare organizations must navigate a…
Oura carries 42 billion hours of health data into its IPO
Oura's IPO paperwork reveals $1.21B in nine-month revenue and a 42 billion hour biometric trove.
Owkin’s AI scientist lands at Boehringer Ingelheim labs
Boehringer Ingelheim licenses Owkin's K Pro AI scientist and multimodal oncology and immunology data.
AI toilet startup banks $10M to chase early cancer signals
Throne Science closes a $10M Series A to push its AI toilet sensor toward early…
Europe approves Vara’s AI to clear normal mammograms on its own
Vara's AI can now report clearly normal mammograms alone after a landmark CE certification.